Novo Nordisk shares rose by more than 5% after the Danish weight-loss drug maker said the Food and Drug Administration accepted a new drug application for a pill form of its popular Wegovy injection.

Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on the ...

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Eli Lilly’s new GLP-1 weight loss drug, in pill form, would be more affordable than Ozempic Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step ...

Drug calculations for the formulation of dosage forms and associated preparations are key activities in pharmaceutical compounding. Calculations determine the amount of drug identified in the request ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy ... announced by Eli Lilly on Thursday morning. The drug, orforglipron, is a GLP-1, a class of drugs that ...

Cannabidiol (CBD) itself doesn't show up on a drug test. These tests are designed to detect tetrahydrocannabinol (THC), the compound in cannabis that causes a high. While many CBD products are labeled ...

Fenugreek has many dosage forms used in studies, including cooked leaves, raw seeds, powders, and extracts. Clinical trials have shown promise, but more studies are needed. 2. Improves Gut Health A ...

🚨NEW DRUG TO REGROW TEETH ENTERS HUMAN TRIALS Japanese researchers developed a drug to regrow teeth, set to begin human trials in September. The drug blocks the USAG-1 protein, which suppresses ...

How much alpha-lipoic acid should you take a day? There are no official alpha-lipoic acid dosage recommendations. Doses of 600-1,800 milligrams a day have been used to treat diabetic nerve pain.

In the results Syntis announced, the drug was delivered in a liquid form via a tube directly to the small intestine so that researchers could check that the polymer coating formed as expected.